You can draw your own conclusions as to why the posters who

New Post Public Reply Private Reply Replies (2) Message Board
Mo
1,156
You can draw your own conclusions as to why the posters who admit they are not IPIX shareholders continue to post on the other board on a 3 cent stock? It has been a difficult time for actual IPIX shareholders since the B-CV19 trial failed to meet endpoint goals. I personally and incorrectly believed that Brilacidin would meet endpoints in the CV19 trial based on previous success in efficacy and safety in other trials and the extensive testing at the Regional Biocontainment Lab. The sad truth is that IPIX share price would be in the dollars per share today vs 3 cents if this trial had been a success. There are endless people and organizations that some want to point fingers at for this failure including the FDA, Fauci, Leo, the Russians, CRO’s etc. Everyone has their own list and ranking of the culprits.

I personally only have 2 entities to blame.

#1 The Criminal Hedge Fund Short Selling Cabal.

IMO this NSS attack has been in place for 7 years or so. Leo’s biggest fault was not recognizing this sooner and raising cash while SP was over $2 per share. IMO if the hedge funds had not illegally targeted IPIX, Leo would have been able to raise sufficient cash without significant dilution. If capital had not been so extremely expensive due to artificial and illegal SP compression, Brilacidin would have been an approved drug long before the world had ever heard of Covid. The only glimmer of good news is that the criminals continue to have massive NSS exposure. If they had covered their naked position on IPIX, the paid multi identities would be long gone. Their plan is to never have to cover their position by putting their targeted companies out of business. To force a NSS cover, Leo would need to execute significant milestones (major license agreement, merge or buyout). IPIX investors that have hung on to some or all of their position can only hope Leo can put some type of deal together. The verbiage in the recent 10-Q indicates that IPIX science will not advance until some type of structured deal is in place. Until that time IMO Leo will continue to minimize expenses.

#2 Myself.

No one put a gun to my head to buy IPIX shares. I did my own due diligence and weighed what I felt were the risks vs the rewards and incorrectly determined that IPIX was a potentially lucrative investment. Up to this point in time I have been wrong in my assessment. Time will tell if IPIX will become a profitable investment but all prior guestimations of potential SP went out the window with the failed trial. Every SP guestimation was based on the assumption that Brilacidin would become a dominant treatment for CV19 which is highly unlikely at this point in time. That assumption has not come to fruition.

There are IPIX investors that I personally know who have completely sold their entire position and moved on, many of who have sold 20% to 50% of their position. There are also a few investors that continue to add to their positions in this 3 cent range to lower their average cost. IMO any investor who intended to sell some or all of their IPIX shares has already done so.

So what now? Those of us who have held a significant percentage of our IPIX holdings can only wait while IPIX appears to be in a holding pattern. Either Leo is successful in putting together some type of deal or structure whereas shareholders could still potentially make a profit or if not IPIX SP will continue to drift lower. I still believe in the science and I am hopeful that Leo can pull something off. As we wait do not forget who is responsible for the position IPIX is in.


14

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lindian's Bold Leap into Rare Earths Processing

Updated Category News Views 2

Changing the Game in Rare Earths When Lindian Resources announces a partnership, it's not just window dressing. This time, they've linked arms with Carester SAS for a hefty venture into oxide separation. The scope? An 8,000-tonne REO facility in Kazakhstan, a place already stamped as a geological treasure chest. We're staring at what could potentially be a new dawn for...

Continue Reading
Baystate Noble Plans Major ED Expansion for Future Needs

Updated Category News Views 2

A Trusted Name in Healthcare Steps Up When a healthcare player like Baystate Health decides to jump into the deep end with an expansion project, you know they're not just doodling on napkins. With a legacy stretching back to 1883, Baystate Health, anchored deeply in western New England, isn't just expanding for fun—it's a move to cement its position as a crucial...

Continue Reading
Mammotome Ramps Up to Tackle Biopsy Needle Shortage

Updated Category News Views 0

A Needle in High Demand There's no beating around the bush: we're staring at a breast biopsy needle shortage that's tossing the healthcare sector into a tizzy. It’s a sterner cocktail when you think that the procedure's delay isn't just a procedural hiccup. It’s a nerve-wracking limbo for patients teetering on the edge of a potential cancer diagnosis. That's where...

Continue Reading
Qapture Expands Global DeFi Reach with Key Acquisitions

Updated Category News Views 6

Qapture Investments just made a move in the digital finance space that's promising to turn some heads. From acquiring Flammarion Partners to snapping up Hermetik Trading's DeFi strategies, this Bermuda-based investment manager isn't here to play. Led by Frederick Pye, the firm's gearing up for an industry takeover by blending regulation with innovative digital finance...

Continue Reading
Flotek Faces Lawsuit: Investors Urged to Act Fast

Updated Category News Views 3

Flotek's Current Storm: Gather Your Wits, Shareholders If you've staked your hard-earned cash into Flotek Industries, Inc. (FTK), it's high time to buckle up. Those court-blaring sirens aren’t a drill: we're talking class-action territory, people. The Law Offices of Howard G. Smith sound the alarm, calling on investors who’ve had their financial feathers singed to...

Continue Reading
Northern CA Super Lawyers Honor Madigan & Lewis LLP

Updated Category News Views 3

Madigan & Lewis Surges with Prestigious Lawyer Recognitions There are firms that talk the talk, and then there's Madigan & Lewis blowing everyone off the water in Northern California's legal scene. Don't take my word for it—five of their attorneys just got the nod from Super Lawyers in a year brimming with competition. That's no small feat, and it marks them as a...

Continue Reading
Globant Unleashes MuleSoft AI Pod for Faster Integration

Updated Category News Views 0

Unlocking the AI Puzzle: Webinar Speed Dials You ever swim through a mash-up of tech lingo that makes you feel like you're trudging through waist-high molasses? Well, Saddle up because that's exactly where Globant's new MuleSoft AI Pod is heading. Through Glob.AI, they're going all in on turning what used to take months into mere weeks—finally, right? In the business of...

Continue Reading
ITP Media's Bold Move: Ready for Asian Market Surge

Updated Category News Views 3

Pushing Boundaries: ITP Media Group Eyes Asia ITP Media Group isn't here to tiptoe around the media market; they're diving headfirst with the recent takeover of Heart Media Group. A bold move, some might say, in this volatile world of media mergers and acquisitions. But let's break down what this really means. A Strategic Bet on Luxury To start, ITP Media is beefing up...

Continue Reading
TPx Pivots Post-Bankruptcy, Rebuilding for New Growth

Updated Category News Views 15

TPx Rebounds with Stronger Foundation Folks, TPx just got itself a fresh pair of legs to stand on. Emerging from the labyrinth of Chapter 11 bankruptcy, TPx has managed to shave off a cumbersome load of debt and cement a pathway to long-term success. A court nod from the U.S. Bankruptcy Court for the Southern District of Texas confirmed their reorganization plan. It's a...

Continue Reading
Joseph Spine Opens New Regenerative Therapy Center

Updated Category News Views 1

Regenerative Medicine: A New Frontier in Spine Care When spine care gets a facelift, you take notice. Joseph Spine Institute, a heavyweight in the spine care game, just threw hat into the regenerative ring. We're talking about using a patient's own cells to mend what's broken—that's advanced. They're launching a Regenerative Therapy Center in Tampa, ready to offer these...

Continue Reading

Top 5 Most Recently Viewed Articles

Annex Brands Names Ryan Heine as New Executive VP

Updated Category News Views 11

Annex Brands: A Strategic Shift in Leadership Here's a name you might be hearing more of in the franchise sphere: Ryan Heine. Elevated to the role of Executive Vice President at Annex Brands, this longtime insider is stepping up to play an even bigger part in the company's ambition to stretch its arms wider across North America. From Seeds to Branches: Heine's Journey...

Continue Reading
Deep Sky Advances Global Carbon Tech with $40M Bill Gates Boost

Updated Category News Views 181

Deep Sky's Innovative Carbon Capture Initiative Deep Sky, a trailblazing Canadian startup, is making significant strides in the realm of carbon removal. The company has recently completed the construction of what they refer to as the first-ever dedicated test hub for direct air capture (DAC) technologies, located in Alberta. This state-of-the-art Alpha facility has...

Continue Reading
Understanding Market Trends: A Look at Synopsys Short Interest

Updated Category News Views 178

Understanding the Market Sentiment Towards Synopsys Synopsys's short interest has seen a notable decline of 20.09% since the latest reporting. Currently, around 3.24 million shares are sold short, representing about 1.75% of the available shares for trading. Given the current trading volume, it would take approximately 3.14 days for traders to cover their short positions...

Continue Reading
Global Renters Insurance Market Set to Double in 10 Years

Updated Category News Views 193

Exploring the Rapid Expansion of the Renters Insurance Market The global renters insurance market is thriving, underpinned by a surge in consumer awareness regarding tenant risk protection and increasing adoption of digital insurance platforms. Individuals are increasingly investing in renters insurance as it offers financial security, liability coverage, and safeguards...

Continue Reading
Innovations in Canada's Pharmaceutical Packaging Industry by 2034

Updated Category News Views 186

Understanding the Canada Pharmaceutical Packaging Market In today's rapidly evolving healthcare landscape, the Canada pharmaceutical packaging market is set to witness significant growth. Forecasted to expand from USD 7.53 billion to USD 14.43 billion, this trajectory highlights the increasing importance placed on packaging solutions for pharmaceuticals, driven primarily...

Continue Reading